Search for Clinical Trial Results

Sponsored By

Autoimmune Lymphoproliferative Syndrome - 8 Studies Found

Status Study
Withdrawn Study Name: Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Condition:
  • Autoimmune Lymphoproliferative Syndrome
  • Lymphoma

Date: 2012-08-23
Recruiting Study Name: Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition: Autoimmune Lymphproliferative Syndrome
Date: 1999-11-03
Completed Study Name: Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition:
  • ALPS
  • Hypersplenism
  • Lymphadenopathy

Date: 2008-01-15
Interventions:
  • Drug: Valproic Acid Oral admin
Completed Study Name: Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Condition:
  • Autoimmune Disease
  • Lymphoproliferative Disorder

Date: 2001-03-28
Interventions: Drug: Fansidar (pyrimethamine and sulfadoxine)
Completed Study Name: Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Condition:
  • Autoimmune Disease
  • Lymphatic Disease
  • Lymphoproliferative D
    Date: 2003-07-21
    Interventions: Drug: Pyrimethamine
Completed Study Name: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Condition:
  • Lymphoproliferative Disorders
  • Lymphoma

Date: 2003-09-09
Enrolling by invitation Study Name: Comparative Autoantibody and Immunologic Cell Marker Study
Condition:
  • Autoimmune Diseases
  • Lupus Erythematosus, Systemic
  • Communic
    Date: 2015-04-17
Recruiting Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT
Condition:
  • Primary Immunodeficiency Syndromes
  • Congenital Bone Marrow Failure Syndromes
  • Drug: Hydroxyurea Hydroxyurea